9th Circuit Denies Rehearing, Files Amended Opinion In FCA Drug Pricing Suit
SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on Jan. 5 denied a petition for a panel rehearing and a rehearing en banc, issuing an amended opinion of its...To view the full article, register now.
Already a subscriber? Click here to view full article